Skip to content

贝塔仿生

US · BBNX #3406 按市值排名 上市于 2025
16.35 -0.96 -5.55%
实时 - 追踪5344个代码 - 心跳于398秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量增加了1家。
  • 机构持股总比例下降了22.0个百分点。

机构持股

机构持股比例
101.32% -21.98pp
机构数量
173 +1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Hedge Fund37.89%
Mutual Fund35.03%
VC/PE Fund16.25%
Public Company10.40%
Individual/Insider4.40%
Government Pension Fund0.83%
Sovereign Wealth Fund0.37%
Private Company0.30%
Insurance Company0.17%

主要股东 截至 2026-06-30

Eventide Asset Management, LLC 11.88% · 6.25M 股
Soleus Capital Management, L.P. 8.35% · 4.39M 股
Morgan Stanley 8.02% · 4.22M 股
Sands Capital Alternatives, LLC 7.04% · 3.71M 股
BlackRock 6.35% · 3.34M 股
Divisadero Street Capital Management, LP 5.84% · 3.07M 股
Soleus Capital LLC 5.12% · 2.70M 股
Point72 Asset Management, L.P. 4.28% · 2.25M 股
Vanguard Capital Management, LLC 3.89% · 2.05M 股
Vestal Point Capital, LP 3.04% · 1.60M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 20次买入 · 30次卖出

姓名职务持股比例
Sean Saint Chief Executive Officer 0.76%
Mike Mensinger Chief Product Officer 0.34%
Steven Russell Chief Medical Officer 0.32%
Stephen Feider Chief Financial Officer 0.30%
Mark Hopman Chief Commercial Officer 0.11%
Maria Palasis Independent Director 0.06%
Adam Lezack Independent Director 0.05%
Gerard Michel Independent Director 0.02%
Sean Carney Independent Director 0.02%
Daniel Dearen Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-30 Mark Hopman Chief Commercial Officer Automatic Disposition -370 $18.96
2026-09-21 Christina Jones Independent Director Automatic Disposition -6,430 $23.00
2026-09-15 Mark Hopman Chief Commercial Officer Automatic Disposition -30,779 $20.13
2026-09-15 Mike Mensinger Chief Product Officer Automatic Disposition -2,650 $22.00
2026-09-13 Mark Hopman Chief Commercial Officer Automatic Disposition -775 $15.52
2026-09-08 Mark Hopman Chief Commercial Officer Open Market Disposition -35,994 $18.46
2026-09-02 Sean Saint Chief Executive Officer Automatic Disposition -5,641 $20.08
2026-09-01 Sean Saint Chief Executive Officer Open Market Disposition -16,867 $19.11
2026-09-01 Stephen Feider Chief Financial Officer Open Market Disposition -6,675 $19.11
2026-09-01 Steven Russell Chief Medical Officer Open Market Disposition -4,221 $19.11
2026-09-01 Mark Hopman Chief Commercial Officer Open Market Disposition -5,327 $19.11
2026-09-01 Mike Mensinger Chief Product Officer Open Market Disposition -4,375 $19.11
2026-06-28 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -10,000 $5.10–17.05
2026-06-23 Christina Jones Independent Director Automatic Disposition -1,406 $15.00
2026-06-23 Mark Hopman Chief Commercial Officer Automatic Disposition -1,258 $15.01
2026-06-03 Christina Jones Independent Director Automatic Disposition -2,811 $14.00
2026-06-03 Mark Hopman Chief Commercial Officer Automatic Disposition -275 $12.31
2026-06-01 Sean Saint Chief Executive Officer Open Market Disposition -16,872 $12.61
2026-06-01 Stephen Feider Chief Financial Officer Open Market Disposition -6,676 $12.61
2026-06-01 Steven Russell Chief Medical Officer Open Market Disposition -4,222 $12.61

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

贝塔仿生 讨论区 0 条评论

发表评论